|
|
 |
|
Viewing report
|
|
|
|
Competitor Analysis: BlyS, BAFF & APRIL Antagonists
La Merie Publishing, Feb 2010, Pages: 12
The present Competitive Intelligence Report about BlyS, BAFF & APRIL Targeted Therapy provides a competitor evaluation in the field of molecules targeting B-lymphocyte stimulator (BlyS), B-cell activating factor of the TNF family (BAFF) and of a proliferation-inducing ligand (APRIL) as of February 2010. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report includes a compilation of currently active projects in research and development of antibodies and antibody-based molecules targeting B-lymphocyte stimulator (BlyS), B-cell activating factor of the TNF family (BAFF) and of a proliferation-inducing ligand (APRIL) for treatment of inflammatory and autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis and multiple sclerosis. In addition, the report lists company-specific R&D pipelines of PSMA & PSA targeted therapeutics. Competitor projects are listed in a tabular format providing information on:
- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Company,
- Product Category,
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
Customers who bought this item also bought
Pharmaceutical Industry Dynamics 2010: Licensing Opportunities: Rheumatology
Drug Delivery in Cancer - Technologies, Markets and Companies
Competitor Analysis: EGF-R Agonists and Antagonists
Competitor Analysis B7 – CD28/CTLA-4 Pathway
Competitor Analysis - Sphingosine-1-Phosphate (S1P)
The Global Competitive Landscape of Antibody Drug Development in Cancer: The Faster Route to Consider Your Options and Position of Others
Competitor Analysis - Antibody Therapy of Inflammatory and Autoimmune Diseases
Alzheimer Disease - New Drugs, Markets and Companies
Pharmaceutical Company Outlook to 2015
Pain Therapeutics - Drugs, Markets and Companies
|
|
|
|
